HomeNewsBusinessCompaniesGlenmark Generics gets US FDA nod for cirrhosis drug

Glenmark Generics gets US FDA nod for cirrhosis drug

Glenmark Generics has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).

July 13, 2011 / 14:58 IST

Story continues below Advertisement

Moneycontrol Bureau

Glenmark Generics has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC). PBC is a chronic liver disease that slowly destroys the ducts that drain bile in the liver. Glenmark

first published: Jul 13, 2011 09:56 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Glenmark Generics gets US FDA nod for cirrhosis drug

Glenmark Generics has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application (ANDA) for Ursodiol tablets used in treatment of patients with primary biliary cirrhosis (PBC).

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links